Preclinical trial of the multi-targeted lenvatinib in combination with cellular immunotherapy for treatment of renal cell carcinoma
多靶点仑伐替尼联合细胞免疫治疗肾细胞癌的临床前试验
期刊:Experimental and Therapeutic Medicine
影响因子:2.4
doi:10.3892/etm.2017.4858
Chengkuan Cai, Jingyuan Tang, Baixin Shen, Liucheng Ding, Yunpeng Shao, Zhengsen Chen, Yinchao Ma, Haoliang Xue, Zhongqing Wei